Aceclofenac Safety in Renal Impairment

Introduction to Renal Impairment with NSAIDs

The American Academy of Family Physicians recommends that NSAIDs should not be used in patients with renal disease 1
The administration of NSAIDs to patients with cirrhosis and ascites is associated with a high risk of developing acute renal failure, hyponatremia, and diuretic resistance, as noted by the Journal of Hepatology 2

NSAIDs like aceclofenac impair glomerular filtration rate due to reduced renal perfusion secondary to inhibition of renal prostaglandin synthesis, according to the Journal of Hepatology 2
The American Academy of Family Physicians suggests that NSAIDs should be used with caution when combining with other medications that potentially decrease renal function, such as ACE inhibitors and beta blockers 1

Approximately 2% of patients stop taking NSAIDs due to renal complications, as reported by the American Academy of Family Physicians 1
The American Academy of Family Physicians notes that NSAIDs can lead to hypertension, with a mean blood pressure increase of 5 mm Hg with NSAID use 1
The American Academy of Family Physicians also states that NSAIDs can interfere with the efficacy of antihypertensive medications 1

The American Academy of Family Physicians recommends considering acetaminophen (paracetamol) as a first-line agent for mild to moderate pain in patients with renal impairment 3

If NSAIDs must be used in patients with mild renal impairment, the American Academy of Family Physicians suggests using the lowest effective dose for the shortest duration possible 3
The American Heart Association, as published in Circulation, recommends monitoring renal function and electrolytes regularly in patients with mild renal impairment taking NSAIDs 4
The American Academy of Family Physicians advises being vigilant for signs of fluid retention, hypertension, or worsening renal function in patients taking NSAIDs 1

Extended use of non‑steroidal anti‑inflammatory drugs (NSAIDs) for pain management is strongly associated with the development of chronic kidney disease in adult patients, based on observational data published in Kidney International (2021) 5.

In patients with a solitary kidney for whom NSAID therapy cannot be avoided, renal function and electrolyte levels should be monitored closely: obtain a baseline serum creatinine, repeat testing 3–5 days after starting the drug, and then perform weekly assessments while therapy continues. This monitoring protocol is recommended by experts in cardiovascular medicine (Circulation 2019) 6.